NATHAN DOSSEY: Open Payments
NPI 1013416759 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,855 in 111 payments from 15 companies in 2025. Trend: 2023 $2,196 · 2024 $2,738 · 2025 $2,855
Food & beverage: $2,659Education: $197
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 28 | $758 |
| Regeneron Healthcare Solutions, Inc. | 15 | $580 |
| GENZYME CORPORATION | 15 | $324 |
| Novartis Pharmaceuticals Corporation | 13 | $272 |
| GlaxoSmithKline, LLC. | 14 | $256 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $112 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Amgen Inc. | 5 | $100 |
| Cycle Pharmaceuticals Inc | 3 | $69 |
Products named: DUPIXENT, FASENRA, AIRSUPRA, TEZSPIRE, NUCALA, NEFFY, XOLAIR, CUVITRU.
Industry payments across NY — which companies pay providers there.
